ELLEN HANISCH: Open Payments
NPI 1346248754 · GIG HARBOR, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 32 payments from 20 companies in 2025. Trend: 2023 $165 · 2024 $1,250 · 2025 $836
Food & beverage: $736Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $184 |
| Incyte Corporation | 3 | $139 |
| ABBVIE INC. | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| Stemline Therapeutics Inc. | 1 | $34 |
| TerSera Therapeutics LLC | 1 | $34 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| Blueprint Medicines Corporation | 1 | $30 |
Products named: ENHERTU, OPDIVO, LIBTAYO, Orserdu, Zoladex, KISQALI, AYVAKIT, XT CDX.
Industry payments across WA — which companies pay providers there.
